Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innov. LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10p -3.51% 2.75p 2.70p 2.80p 2.85p 2.75p 2.85p 179,681 11:37:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 8.8 0.5 0.1 27.5 21.52

Surgical Innovations Share Discussion Threads

Showing 10676 to 10700 of 10700 messages
Chat Pages: 428  427  426  425  424  423  422  421  420  419  418  417  Older
DateSubjectAuthorDiscuss
07/12/2018
11:16
Bashor I also await the January update with a high degree of anticipation and am currently wondering whether to top up. The sub 3p price is inviting me to buy. GLA
contact2fsnetcouk
05/12/2018
16:10
I don’t see any fundamental reason to sell so will be adding when funds allow, unless of course some bad news breaks
bashor
05/12/2018
13:53
A good time to shake the tree
mandate
05/12/2018
13:48
Yes I'm sure it does
meijiman
05/12/2018
12:23
What does someone know that’s not in the public domain, does this have something to do with the new advisor/broker I wonder
bashor
27/11/2018
11:02
“we continue to look forward to the second half of the year and beyond with confidence." I’m looking forward to an early January update to see if they delivered a strong H2 and can follow up with an upbeat H1/19 statement
bashor
17/11/2018
18:34
hTTps://www.telegraph.co.uk/news/2018/11/05/heart-surgeon-turned-training-pioneering-robot-used-operation/ Elemental Healthcare are right to target training as a priority in the latest SUN initiative as the above piece highlights The NHS will be forced into getting their house in order regards to robotic surgery and having proper accreditation to set standards for operators of robotic surgery instruments. Companies that take the lead in this , and provide the proper trainers and training courses on such instruments will reap the rewards as contracts for new robotic surgical equipment are awarded. ''There are around 60 surgical robots in NHS hospitals. Lancashire Teaching Hospitals, which has been using a Da Vinci robot for a year, said it noticed a "significant reduction in patient recovery times and complications".'' Robotic surgery is here to stay and IMO the NHS will be forced to expand its use to counteract the loss of doctors/surgeons from the NHS to overseas jobs. However doing dry run training does not cut it ''Yesterday a coroner was told that the lead surgeon, Sukumaran Nair, subsequently admitted to a colleague that he could could have done more “dry-run” training on the sophisticated system'' A robotic operator needs to be ''passed out'' as having proved to meet a measurable standard of competence on the particular robot which he is going to use. ie a clear level of competence in the use of the robotic machine must be demonstrated to the accredited trainer , records of the course attended and marks attained by the attendee recorded and kept before the operator is deemed competent to use the machine. The relevant NHS body/person in charge of safety standards regarding surgical operations needs to have input and sign off all of the above The need for another accredited NHS operator present for a set number of operations to mentor the newly accredited operator , together perhaps with a trainer that carried out the operator training also needs to be addressed and agreed by the DoH as the article shows . So work and monies to be made for those that can provide such services.
buywell3
17/11/2018
18:05
NHS publishes £300m contract for new surgery robots - The Telegraph hTTps://www.telegraph.co.uk › Business Jan 27, 2018 - Previously, the most that had been spent on robotics in one go was the £74m tender which the Countess of Chester Hospital NHS Foundation Preparing for the surgical robot boom 12th June 2018 With greater investment from healthcare organisations and surgical robot technology about to become generic, the conditions are perfect for a boom in the surgical robotics market.
buywell3
12/11/2018
22:08
Adam Power, Group Development Director of Surgical Innovations Group plc, commented: The market for surgical robots in the UK is limited by the cost and by the range of applications for which existing competitors are appropriate. ‘Dexter’ offers a much broader range of surgical opportunites and employs a novel funding model. As a consequence, we expect ‘Dexter’ by DistalMotion SA to address the issues limiting the growth of surgical robots in the UK and to be a more acceptable solution for NHS and Private Hospitals.
buywell3
12/11/2018
22:02
Re latest RNS ... which is good news That SUN were chosen is a vote of confidence by Distalmotion Other bigger USA robot manufacturers will be taking a close look at developments I feel With Dexter, the robot of the Swiss start-up Distalmotion, hospitals can reduce the costs for surgeries by more than 90% compared to traditional robotic solutions. Distalmotion has now signed a first distribution agreement for Dexter. Today’s surgical robots have their roots in remote surgery for the military. They were designed to allow surgeries even when the surgeon is on another continent as the patients. This concept led to very complex and expensive solutions, which need a lot of training. Therefore, the use of robots is still not widespread. Distalmotion wants to change that with the new approach. Its surgical robot Dexter has been designed with the daily work of surgeons in mind. The new concept has several advantages. Dexter will be used only for long and complex tasks such as suturing and dissection, while the surgeon performs short and specialized tasks such as stapling and vessel sealing. In addition, Distalmotion’s robot will not replace the assistant like traditional surgical robots. The focus makes Dexter less complex and more affordable. Surgeons and assistants do not have to learn new procedures; they can just use the robot for some clearly defined tasks. The surgeon does not have to be outside of the operating room to control the robot; he can remain sterile at the patient and switch between robotics and laparoscopy in less than 20 seconds. ‘Dexter’ will be CE marked in mid-2019. The robot will not be sold. The business model includes robot rental plus recurring revenues from consumables. The “pay-per-use-model” will make the market entry easier for the start-up. Distalmotion has its own sales organisation for Germany, Switzerland, Austria and France. This week, Surgical Innovations Group plc – the designer and manufacturer of innovative technology for minimally invasive surgery – has announced that its wholly-owned subsidiary, Elemental Healthcare Limited, has signed a three-year exclusive UK distribution agreement with Distalmotion. It is the first distribution agreement for the Swiss start-up. Adam Power, Group Development Director of Surgical Innovations Group plc, commented: The market for surgical robots in the UK is limited by the cost and by the range of applications for which existing competitors are appropriate. ‘Dexter’ offers a much broader range of surgical opportunites and employs a novel funding model. As a consequence, we expect ‘Dexter’ by DistalMotion SA to address the issues limiting the growth of surgical robots in the UK and to be a more acceptable solution for NHS and Private Hospitals.
buywell3
10/11/2018
11:06
Hope you're right, I found some certificates recently and bought a few more to make up a small but decent holding (just in case) the new crew managed to make something of the business.
gbh2
10/11/2018
10:58
There has appeared to be a big overhang of shares recently which I'm hoping has now cleared. Ultimately the fundamentals will move the share price up with a much improved 2nd half of 2018 along with a promising 2019.
jmf69
10/11/2018
10:00
As you say, I don't Know, but I did record the volume they accrued during their tenure and I've not seen sufficient volume of sales to suggest otherwise. However as I'm unsure as to whether they would need to declare the "Sells" it is pure guess work based on the level at which some one can make money selling at these low prices.
gbh2
09/11/2018
19:11
How do you know they still have them and 100’s of thousands is hardly a big deal or am I missing your point, my point is I actually see real value at this level as long as they’ve been telling the truth
bashor
09/11/2018
18:23
Don't forget you have the inept old lags that made up the previous BOD sitting on hundreds of thousands of of cheap shares that they'll want to get rid of.
gbh2
09/11/2018
17:31
What is it going to take to get this share price back to the 4-4.5p Range? good solid growth this year and a positive outlook for 2019, with free cash flow to backup a share buyback, that’s my wish list for Xmas, am I been too reserved with the 4-4.5p target
bashor
08/11/2018
21:10
We need to see some major institutional investor or at least some interested analysts, the PR feels like it’s starting but still room for much more, I’m hopeful this company is now on the right track with a much better board and hopefully focused on reinstating shareholder value, I’ll invest more funds when I can see some serious interest but only then, 2 trades of 500K is hardly going to move the dial, still I’d rather the BOD keep there powder dry and under promise and over deliver
bashor
08/11/2018
19:05
Another 500k buy showing just before the close at 3.1
jmf69
08/11/2018
18:59
I’m sure 3.2p will look like a very good buy sometime in the new year
bashor
08/11/2018
18:19
Delayed 500k buy showing at 3.2
jmf69
08/11/2018
11:52
http://www.startupticker.ch/en/news/november-2018/distalmotion-facilitates-the-breakthrough-of-surgery-robots
jmf69
06/11/2018
13:30
"This makes DEXTER accessible for every laparoscopic operating room in the world". Is this a wise move I've seen a few of the DEXTER episodes on TV and what with all knife crime at the moment!! Maybe our man at the Vatican could advise? VZ
van zandt
06/11/2018
08:52
My only surprise is that you know what the OED is :)) htTps://www.biopole.ch/company/distalmotion/
gbh2
06/11/2018
08:14
Gbh - I’ll send you a link to the OED entry for ‘distribution’.
xylemflow
06/11/2018
07:46
No mention of being involved with it's production though.
gbh2
Chat Pages: 428  427  426  425  424  423  422  421  420  419  418  417  Older
Your Recent History
LSE
SUN
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181211 13:02:33